Skip to Main Content

Insight

August 20, 2026
Cannabis and Psychedelics Monthly Newsletter

the buzz: Cannabis News & Policy Update | August 2026

Welcome back to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry.

In this edition of the buzz, highlights include:

  • Hemp definition delayed—for now:  Senate CR (if enacted) will push back key portions of the new federal hemp definition to Dec. 11, but the synthetic cannabinoid ban still hits November 12 
     
  • Rescheduling grinds forward:  DEA wraps its hearing with briefs due August 17 and no set deadline for the judge's report; SAM fights to keep cannabis businesses out of the D.C. Circuit litigation
     
  • 280E & the new AG:  Newly confirmed AG Todd Blanche sidesteps rescheduling and 280E questions; in NM Top Organics, IRS argues April rescheduling order offers no retroactive relief
     
  • State Markets in flux:  MA to vote on ballot measure to eliminate licensed adult-use sales; UT accepting rural medical cannabis pharmacy licenses applications through Sept. 2; NE's first medical licenses expected Sept.
     
  • Hemp patchwork widens:  DE greenlights THC beverages; hemp industry sues MO over its new limits; NC delays its hemp bill; TX reinstates Schedule I language

Read Here

Want the buzz delivered monthly?
Never miss a cannabis news and policy update. Use the button below to sign up for future monthly newsletters.

Sign Up


Subscribe to get our Insights delivered to your inbox.

This publication is designed to provide general information on pertinent legal topics. The statements made are provided for educational purposes only. They do not constitute legal or financial advice nor do they necessarily reflect the views of Holland & Hart LLP or any of its attorneys other than the author(s). This publication is not intended to create an attorney-client relationship between you and Holland & Hart LLP. Substantive changes in the law subsequent to the date of this publication might affect the analysis or commentary. Similarly, the analysis may differ depending on the jurisdiction or circumstances. If you have specific questions as to the application of the law to your activities, you should seek the advice of your legal counsel.

Holland & Hart Authors

Related Capabilities

Cannabis and Psychedelics
DISCLAIMER

Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.